About TransCure bioServices
TransCure bioServices is a company based in Archamps (France) founded in 2012 by Patrick Nef.. TransCure bioServices has raised $3.58 million across 6 funding rounds from investors including European Union, Financiere Arbevel and Cathay Capital. TransCure bioServices offers products and services including CD34+ Humanized Mouse, Humanized Liver Mouse, Double Humanized Mouse, and Conventional Mouse Model. TransCure bioServices operates in a competitive market with competitors including GenOway, PsychoGenics, PharmaLegacy Laboratories, InVivo Biosystems and Noble Life Sciences, among others.
- Headquarter Archamps, France
- Founders Patrick Nef
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.58 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
European Union
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TransCure bioServices
TransCure bioServices offers a comprehensive portfolio of products and services, including CD34+ Humanized Mouse, Humanized Liver Mouse, Double Humanized Mouse, and Conventional Mouse Model. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Model for human immune system in efficacy testing
For hepatotoxicity and drug evaluation studies
Combines immune and liver systems for research
Standard models for general preclinical work
Funding Insights of TransCure bioServices
TransCure bioServices has successfully raised a total of $3.58M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(04 Jul 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series B - TransCure bioServices | Valuation |
investors |
|
| Jun, 2019 | Amount | Series A - TransCure bioServices | Valuation | Financiere Arbevel |
|
| Jun, 2019 | Amount | Grant - TransCure bioServices | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TransCure bioServices
TransCure bioServices has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Financiere Arbevel and Cathay Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cathay Capital is engaged in global investment and transformation.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investment management services are provided for clients in Paris.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TransCure bioServices
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TransCure bioServices
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Transcure Bioservices Comparisons
Competitors of TransCure bioServices
TransCure bioServices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenOway, PsychoGenics, PharmaLegacy Laboratories, InVivo Biosystems and Noble Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| domain | founded_year | HQ Location |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| domain | founded_year | HQ Location |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| domain | founded_year | HQ Location |
Animal models are supplied for in-vivo analytical services.
|
|
| domain | founded_year | HQ Location |
Preclinical contract research organization offering standard GLP and non-GLP services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Transcure Bioservices
Frequently Asked Questions about TransCure bioServices
When was TransCure bioServices founded?
TransCure bioServices was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is TransCure bioServices located?
TransCure bioServices is headquartered in Archamps, France. It is registered at Archamps, Haute-savoie, France.
Who is the current CEO of TransCure bioServices?
Patrick Nef is the current CEO of TransCure bioServices. They have also founded this company.
Is TransCure bioServices a funded company?
TransCure bioServices is a funded company, having raised a total of $3.58M across 6 funding rounds to date. The company's 1st funding round was a Grant of $55.99K, raised on Jul 04, 2014.
What does TransCure bioServices do?
TransCure bioServices was founded in 2012 in Archamps, France, within the biotechnology sector. Services are provided to pharmaceutical companies, biotechs, and academic labs using the Humanized Immune System (HIS) mouse model. This platform supports drug profiling for immune-related diseases and anti-HIVAIDS therapies. Immunodeficient mouse strains are engrafted with human CD34 hematopoietic stem cells sourced from cord blood.
Who are the top competitors of TransCure bioServices?
TransCure bioServices's top competitors include GenOway, PsychoGenics and Alpha Genesis.
What products or services does TransCure bioServices offer?
TransCure bioServices offers CD34+ Humanized Mouse, Humanized Liver Mouse, Double Humanized Mouse, and Conventional Mouse Model.
Who are TransCure bioServices's investors?
TransCure bioServices has 5 investors. Key investors include European Union, Financiere Arbevel, Cathay Capital, Eurostars, and Savoie Mont Blanc Angels.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.